[L]ongtime listeners to our internet podcast, PID Radio, may remember that back in 2009 or so, Derek and I were talking about the government’s proposal that Swine Flu vaccine manufacturers be allowed to add an adjuvant to their vaccine cocktails to keep costs to a minimum and ‘stretch’ the amount of active ingredients within the vaccine. At the time, health and wellness groups throughout the country made a massive squawk about squalene, the proposed adjuvant that was only permitted in Europe.
Journalist Gary Matsumoto, author of Vaccine A: The Covert Experiment that’s Killing our Soldiers, and Why GI’s Are Only the First Victims, asserts that squalene was included as an adjuvant (read that as ‘money saving measure’) in the Anthrax vaccine given to Gulf War soldiers, and that Gulf War Syndrome is a consequence of squalene’s effect on the immune systems of these brave men and women. In 2009, we managed to remove the squalene inclusion option from vaccines given to US citizens (other than soldiers, that is), but a study released today by the National Institutes of Health (NIH) may change all that.
According to the report, the adjuvant MF59 was used as part of a vaccine trial that included 700 healthy adults aged 19-64 years old. These volunteers were injected with a trial vaccine against H7N9 avian flu virus. H7N9 is currently not efficiently spread from human to human. Most human infections so far (primarily in Southeast Asia) can be traced to contact with fowl of some kind: ducks, geese, chickens. Here’s an excerpt from the most recent evaluation of the H7N9 situation from the World Health Organization (WHO):
Although much remains unknown about this virus, such as (1) the animal reservoir(s) in which it is
circulating, (2) the main exposures and routes of transmission to humans, and (3) the distribution
and prevalence of this virus among people and animals (including the distribution in wild birds), 3
human infection appears to be associated with exposure to infected live poultry or contaminated
environments, including markets where live poultry are sold, given the following:
• Around 80% of human cases report a history of exposure to birds or live poultry markets.
• The viruses isolated from humans are avian influenza viruses and genetically similar to those
isolated from birds and the environment.
• Targeted testing of poultry and environment in live poultry markets that are
epidemiologically linked with human cases of H7N9 infection have revealed more positive
results than testing in areas not linked with human cases.
Current evidence suggests that these avian influenza A(H7N9) viruses do not transmit easily from
poultry or environments to humans, although their transmissibility may be greater compared with
highly pathogenic avian influenza A(H5N1) viruses. [emphasis added]
I find it curious that 375 lab-confirmed cases of H7N9 (115 deaths), the report lists 80% are related to either exposure to poultry or a poultry environment (not sure what they mean by that one). That means 20% may be human to human transmission, which means H7N9 is figuring out how to spread more efficiently. Perhaps, that is why Novartis and other vaccine manufacturers are once again ramping up the trials to receive FDA approval for adjuvant includion. More vaccine, less money–lots of profit. That, after all, is the bottom line.
Squalene is the ‘oil’ (from whales) which is the main ingredient in MF59. This oil has been linked to autoimmune disorders because it kicks the human immune system into overdrive to the extent that our God-given internal police no longer recognize ‘self’, meaning they start turning on our own, friendly cells. It’s like dying of friendly fire.
So, let’s start squawking about squalene again, people!